Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Cell Cycle (Georgetown, Tex.)|January 8, 2015
Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myelomaMegan Y Murray, Lyubov Zaitseva, Martin J Auger, et al.Oncotarget|October 9, 2014
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AMLLyubov Zaitseva, Megan Y Murray, Manar S Shafat, et al.European Journal of Pharmacology|October 22, 2021
Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parametersPeter Kilfoil, Shuyun Lily Feng, Asser Bassyouni, et al.The Lancet. Haematology|December 22, 2015
Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cellsStuart A Rushworth, Genevra Pillinger, Amina Abdul-Aziz, et al.Cancer Research|December 20, 2017
New Perspectives, Opportunities, and Challenges in Exploring the Human Protein KinomeLeah J Wilson, Adam Linley, Dean E Hammond, et al.British Journal of Pharmacology|March 10, 2018
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewersMichael J Curtis, Steve Alexander, Giuseppe Cirino, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Activation of Human CD8+ T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding PeptidesMubarak Almutairi, Adam Lister, Qing Zhao, et al.The Journal of Investigative Dermatology|April 2, 2021
HLA Class-II‒Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive PatientsQing Zhao, Mubarak Almutairi, Arun Tailor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL CellsAdam J Linley, Laura I Karydis, Anil K Mondru, et al.Pageof 5